Mini review · 30 Apr 2024
Mini reviewPublished 30 Apr 2024
Immunogenicity in Biopharmaceuticals
Department of Pharmacology, Heidelberg University, Germany
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In the realm of biopharmaceuticals, ensuring therapeutic efficacy and safety is paramount. However, the immune system's response to these complex therapeutic agents, known as immunogenicity, poses a significant challenge. In this article, we delve into the intricacies of immunogenicity, exploring its causes, consequences, and strategies for mitigation in the development and administration of biopharmaceuticals.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Mini review · 30 Sep 2022
Assessment of Biopharmaceutical Immunogenicity: A Review
Perspective · 30 Aug 2022
Biopharmaceutical Immunogenicity Assessment
Editorial · 31 Jul 2023
Immunogenicity of Biopharmaceuticals: The Immune Response to Therapeutic Proteins
Conference abstract
Processes and protecting agents for drying of biopharmaceuticals
More from this journal
The newest in Clinical Pharmacology & Biopharmaceutics.
Research article · 27 Jul 2026
Qualitative LC/MS Assessment of Fenfluramine Hydrochloride After Dilution in Purified Water : A Preliminary Study and Case Report
Article · 20 Jul 2026
Population Pharmacology: Precision Dosing for Diverse Patients
Article · 17 Jul 2026
Therapeutic Drug Monitoring: Optimizing Therapy, Minimizing Toxicity
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Pharmacology & Biopharmaceutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Louise Reagan”
